Perspective: effect of rosiglitazone on cardiovascular outcomes

Curr Cardiol Rep. 2007 Sep;9(5):343-4. doi: 10.1007/BF02938358.
No abstract available

MeSH terms

  • Cardiovascular Diseases / mortality*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Myocardial Infarction / chemically induced*
  • Myocardial Infarction / epidemiology
  • Odds Ratio
  • PPAR gamma / agonists*
  • Risk Assessment
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*

Substances

  • Hypoglycemic Agents
  • PPAR gamma
  • Thiazolidinediones
  • Rosiglitazone